← Back to Search

Educational Video for Lung Cancer Screening

N/A
Recruiting
Led By Amy R Leader, DrPH, MPH
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to endpoint, up to 1 year
Awards & highlights

Study Summary

This trial looks at using a video to educate people from minority and immigrant communities on lung cancer screening to reduce deaths from lung cancer.

Who is the study for?
This trial is for African American, Korean, or Chinese adults who are current/former smokers aged 50-80 with a significant smoking history. It aims to educate these communities about lung cancer and screening. Children, non-community members, those without a smoking history or prior lung cancer diagnosis/screening are excluded.Check my eligibility
What is being tested?
The study tests the effectiveness of a culturally tailored educational video in promoting understanding and participation in lung cancer screening among vulnerable populations. The intervention includes discussions, media materials, interviews, and tests to measure impact.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to endpoint, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to endpoint, up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To understand barriers and opportunities for engaging three culturally distinct populations in lung cancer screening.
Secondary outcome measures
To develop three culturally tailored educational videos about lung cancer and the benefits of lung cancer screening
To test the impact of the videos on susceptibility to lung cancer, knowledge of lung cancer screening, and intentions to undergo lung cancer screening in a diverse sample of at-risk individuals.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Arm III (Aim 3) (video, test)Experimental Treatment2 Interventions
Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.
Group II: Arm II (Aim 2) (video, interview)Experimental Treatment2 Interventions
Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.
Group III: Arm I (Aim 1) (focus group)Experimental Treatment1 Intervention
Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~130

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
445 Previous Clinical Trials
145,319 Total Patients Enrolled
Amy R Leader, DrPH, MPHPrincipal InvestigatorThomas Jefferson University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment to this experiment currently being accepted?

"According to clinicaltrials.gov, this medical study is still enrolling participants. It was originally posted on March 1st 2023 and had its last edit on August 18th of the same year."

Answered by AI

How many participants are being observed in this research endeavor?

"Affirmative. The clinicaltrials.gov page for this particular trial affirms that it is currently seeking participants; the record was initially posted on March 1st of 2023 and has been edited as recently as August 18th, 2023. 120 individuals must be recruited from a single medical centre."

Answered by AI
~40 spots leftby Dec 2024